ARTICLE | Clinical News
Immunomedics regulatory update
June 20, 1994 7:00 AM UTC
IMMU (Morris Plains, N.J.) received Canadian Patent No. 1,329,119 covering the use of cytotoxic agents for treating cancer and infections or for immunosuppressing a patient for organ transplantation, ...